MicroRNA-630 May Confer Favorable Cisplatin-Based Chemotherapy and Clinical Outcomes in Non-Small Cell Lung Cancer by Targeting BCL-2
Oncotarget - United States
doi 10.18632/oncotarget.24474
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 11, 2018
Authors
Publisher
Impact Journals, LLC